Psychiatry and Clinical Psychopharmacology

Papers
(The median citation count of Psychiatry and Clinical Psychopharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)
ArticleCitations
The psychometric properties of the Generalized Anxiety Disorder scale (GAD-7) among Korean university students30
Automatic thoughts, cognitive distortions, dysfunctional attitudes, core beliefs, and ruminative response styles in unipolar major depressive disorder and bipolar disorder: a comparative study10
Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ(1–42)-infused rat model of Alzheimer's disease8
Use of multisensory stimulation interventions in the treatment of major neurocognitive disorders8
Social cognition and emotion regulation may be impaired in adolescents with obesity independent of the presence of binge eating disorder: a two-center study6
Video/Computer Game Addiction among University Students in Ghana: Prevalence, Correlates and Effects of Some Demographic Factors5
Reliability, validity, and factorial structure of the Turkish version of the Freiburg Mindfulness Inventory (Turkish FMI)4
Pregabalin abuse among patients with opioid use disorders may increase the severity of withdrawal symptoms: a single-center, case-control study4
Early effects of selective serotonin reuptake inhibitors (SSRIs) on cornea and lens density in patients with depression3
Antineuronal antibodies and 8-OHdG an indicator of cerebellar dysfunction in autism spectrum disorder: a case–control study2
CNR2 rs2229579 and COMT Val158Met variants, but not CNR2 rs2501432, IL-17 rs763780 and UCP2 rs659366, contribute to susceptibility to substance use disorder in the Turkish population2
Validity and reliability study of the Turkish version of the tolerance for mental pain scale-102
Is restless legs syndrome related with depression/anxiety disorders or medications used in these disorders? A cross-sectional, clinic-based study2
Adjunct ketamine treatment effects on treatment-resistant depressive symptoms in chronic treatment-resistant schizophrenia patients are short-term and disassociated from regional homogeneity changes i2
Efficacy and acceptability of three prolactin-sparing antipsychotics in patient with schizophrenia: a network meta-analysis2
Syrian Civil War’s effects on Turkish school children: prevalence and predictors of psychopathology2
Temperament and Character Traits of Personality in a Sample of Patients Admitted to the Emergency Unit with a Suicide Attempt1
Psychiatric Diagnoses and Prescribing Patterns of Psychotropic Polypharmacy among Children and Adolescents in the Jazan Region, Saudi Arabia1
Endothelial Dysfunction and Arterial Stiffness in Patients with Bipolar Depression1
Distinctive clinical correlates of hazardous drinking1
Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder1
Adult ADHD: Prevalence, Comorbidities, and Patient-Reported Dysfunction in a Tertiary Mental Health Clinic1
Association between emotional functioning and biological rhythm disruptions in patients with schizophrenia1
Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP1
0.010315179824829